g, 5 mmol), CH2Cl2 (2 L), benzaldehyde (1.5 mL, 15 mmol), and
pyrrole (1.4 mL, 20 mmol) were added successively, and the
flask was wrapped in aluminium foil. After purging of the solu-
tion with dry nitrogen for 30 min, BF3–OEt2 (0.82 mL, 6.6
mmol) was added via a hypodermic syringe, and the mixture
was stirred for 1 h at room temperature in a nitrogen atmos-
phere. Then, 2,3,5,6-tetrachloro-1,4-benzoquinone (DDQ; 3.4
g, 15 mmol) was added to the reaction mixture, and the result-
ing solution was gently further stirred at room temperature for
1 h. Triethylamine (0.9 mL, 6.6 mmol) was added and the vola-
tile fractions were removed from the reaction mixture under
reduced pressure. The resulting dark purple residue was sub-
jected to column chromatography on silica gel (Wakogel C-300)
with CH2Cl2–n-hexane (2 : 1) as eluent. The second fraction,
purple in color, was collected and evaporated to dryness. The
purple residue was recrystallized from CHCl3–n-hexane to give
5-[2Ј-(1Љ,3Љ-dithiacyclohexan-2Љ-yl)phenyl]-10,15,20-triphenyl-
porphyrin (3; 550 mg, 15%) as a purple powder. CHN analysis:
found C, 77.81; H, 5.19; N, 7.76 (calcd for C48H36N4S2: C, 78.66;
H, 4.95; N, 7.64%). FAB-MS for C48H37N4S2 (MHϩ): m/z 733.
methyl)triphenylphosphonium bromide (1.73 g, 17.3%) as
white crystals. FAB-MS for C24H21BrNP: C24H21NPϩ; m/z 354,
(C24H21NPϩ)2BrϪ; m/z 787. Mp 260–261 ЊC (decomp.). 1H
NMR (CDCl3): δ 5.8 (d, 2H, CH2), 7.1 (d, 1H, 3-pyridyl-H),
7.6–7.9 (m, 16H, phenyl and 5-pyridyl-H), 8.0 (t, 1H, 4-pyridyl-
H), 8.3 (s, 1H, 6-pyridyl-H).
Synthesis of 5-[2Ј-(2Љ-pyridylethenyl)phenyl]-10,15,20-
triphenylporphyrin (stilbazole–porphyrin; 1)
5-(2Ј-Formylphenyl)-10,15,20-triphenylporphyrin (4; 193 mg,
0.3 mmol) and (2-pyridylmethyl)triphenylphosphonium
bromide (192 mg, 0.3 mmol) were dissolved in dry CH2Cl2
(10 mL) under nitrogen, and the mixture was stirred at room
temperature prior to the addition of diazabicyclo[5.4.0]undec-
7-ene (0.13 mL, 0.8 mmol). After 30 min, the reaction mixture
was directly subjected to column chromatography on silica
gel (Wakogel C-300) using CH2Cl2 as eluent. The second and
third of the three major fractions were collected separately
and recrystallized from CHCl3–MeOH (1 : 1) to give (E)-5-[2Ј-
(2Љ-pyridylethenyl)phenyl]-10,15,20-triphenylporphyrin (trans-
1; 101 mg, 47%) and cis-1 (64 mg, 30%), respectively. trans-1:
CHN analysis: found C, 84.25; H, 5.01; N, 9.60 (calcd for
C51H35N5: C, 85.33; H, 4.91; N, 9.76%). Mp 251–253 ЊC
1
Mp 320–322 ЊC (decomp.). H NMR (CDCl3): δ Ϫ2.7 (s, 2H,
NH), 1.6 (m, 2H, SCH2CH2CH2S), 1.9 and 2.3 (dt, 4H, SCH2),
4.8 (s, 1H, SCH(Ph)S), 7.5 (m, 12H, m-phenyl and p-phenyl),
8.2 (m, 7H, o-phenyl), 8.7–8.8 (d, 8H, pyrrole).
1
(decomp.). FAB-MS for C51H35N5 (MHϩ): m/z 718. H NMR
Synthesis of 5-(2Ј-formylphenyl)-10,15,20-triphenylporphyrin
(C6D6): δ Ϫ2.0 (s, 2 H, NH), 6.1 (t, 1H, 5-pyridyl-H), 6.3
(4)13
(d, 1H, 3-pyridyl), 6.4 (t, 1H, 4-pyridyl), 7.5 and 7.9 (2 d, both
3
1H, JHH = 16.0 Hz, CH᎐CH), 7.6–7.8 (m, 12H, m-phenyl and
᎐
Deprotection of the obtained 5-[2Ј-(1Љ,3Љ-dithiacyclohexan-
2Љ-yl)phenyl]-10,15,20-triphenylporphyrin was achieved by
reaction with BF3–OEt2 and DDQ. To a CH2Cl2 solution
(300 mL) of 5-[2Ј-(1Љ,3Љ-dithiacyclohexan-2Љ-yl)phenyl]-
10,15,20-triphenylporphyrin (292 mg, 0.4 mmol) were added
BF3–OEt2 (5.0 mL, 41 mmol) and DDQ (5.0 g, 22 mmol), and
the mixture was stirred at room temperature overnight in the
air. The reaction mixture was washed three times with
aqueous Na2CO3 (10%) and dried over MgSO4. Evaporation to
dryness gave a purple powder that was recrystallized from
CHCl3–MeOH (1 : 1) to give 5-(2Ј-formylphenyl)-10,15,20-
triphenylporphyrin (4; 230 mg, 90%) as purple crystals. CHN
analysis: found C, 84.02; H, 4.92; N, 8.63 (calcd for C45H30N4O:
p-phenyl), 7.8 (d, 1H, 6-pyridyl), 8.1–8.4 (m, 7H, o-phenyl),
9.1 (m, 8H, pyrrole). UV–vis (CHCl3): λmax/nm (10Ϫ3 εmax) 646
(4.2), 591 (6.9), 551 (8.5), 516 (21.9), 421 (278), 302 (41.4).
cis-1: CHN analysis: found C, 84.83; H, 5.11; N, 9.74 (calcd
for C51H35N5: C, 85.33; H, 4.91; N, 9.76%). Mp 249–251 ЊC.
FAB-MS for C51H35N5 (MHϩ): m/z 718. 1H NMR (C6D6):
3
δ Ϫ1.8 (s, 2 H, NH), 6.2 and 6.7 (2 d, both 1H, JHH
=
12.5 Hz, CH᎐CH), 6.8 (t, 1H, 5-pyridyl-H), 7.2 (t, 1H, 4-
᎐
pyridyl), 7.5–7.7 (m, 12H, m-phenyl and p-phenyl), 8.0 (d, 1H,
3-pyridyl), 8.7 (d, 1H, 6-pyridyl), 8.2–8.4 (m, 7H, o-phenyl),
9.1 and 9.4 (2 d, 2H and 6H, pyrrole). UV–vis (CHCl3): λmax/nm
(10Ϫ3 εmax) 647 (2.8), 591 (4.3), 550 (5.3), 515 (13.4), 420 (272),
290 (17.6).
1
C, 84.09; H, 4.70; N, 8.72%). Mp 356–359 ЊC (decomp.). H
NMR (CDCl3): δ Ϫ2.7 (s, 2H, NH), 7.7 (m, 12H, m-phenyl and
p-phenyl), 8.4 (m, 7H, o-phenyl), 8.6 (d, 2H, pyrrole), 8.9 (s, 6H,
pyrrole), 9.5 (s, 1H, CHO).
Preparation of zinc porphyrin (2)
The zinc complexes of trans-1 and cis-1 (trans-2 and cis-2) were
prepared by the reaction of trans-1 and cis-1 with Zn(OAc)2. To
a round-bottom flask (200 mL) containing a CHCl3 solution
(100 mL) of trans-1 (143 mg, 0.2 mmol), a saturated MeOH
solution of Zn(OAc)2 (7 mL) was added, and the mixture was
stirred at room temperature for 2 h. Then, the reaction mixture
was washed with brine (100 mL × 3) and dried with Na2SO4.
After the volatile fractions had been removed under reduced
pressure, the purple powder obtained was recrystallized from
CHCl3–MeOH to give trans-2 as purple crystals (134 mg, 86%).
trans-2: FAB-MS for C51H33N5Zn (MHϩ): m/z 780. Mp >237 ЊC
(decomp.). 1H NMR (C6D6): δ 5.9 (t, 1H, 5-pyridyl-H), 6.3
Synthesis of (2-pyridylmethyl)triphenylphosphonium bromide
2-Methylpyridine (18.6 mL, 0.2 mol) and benzoyl peroxide
(0.4 g) were added successively to a suspension of N-bromo-
succinimide (71.2 g, 0.2 mol) in CCl4 (500 mL) with vigorous
stirring, and the mixture was kept at 60 ЊC for 18 h. The
reaction mixture was then cooled in an ice bath and filtered.
The filtrate was concentrated to ca. 100 mL, washed with water,
and then dried over MgSO4. CCl4 and unreacted 2-methyl-
pyridine were removed under reduced pressure (10 mmHg, 30
ЊC) to give 2-bromomethylpyridine as a brown oil. This product
was used directly in the next step without further purification,
since it decomposed easily on standing. 1H NMR (CDCl3): δ 4.7
(s, 2H, CH2Br), 7.2 (m, 1H, 3-pyridyl-H), 7.5 (d, 1H, 5-pyridyl-
H), 7.8 (m, 1H, 4-pyridyl-H), 8.6 (d, 1H, 6-pyridyl-H).14
(d, 1H, 3-pyridyl), 6.4 (t, 1H, 4-pyridyl), 6.6 and 8.2 (2 d, both
3
1H, JHH = 16.0 Hz, CH᎐CH), 6.8 (d, 1H, 6-pyridyl), 7.6–7.9
᎐
(m, 12H, m-phenyl and p-phenyl), 8.3–8.6 (m, 7H, o-phenyl),
9.2–9.3 (m, 8H, pyrrole). UV–vis (CHCl3): λmax/nm (10Ϫ3 εmax
)
A benzene solution (30 mL) of 2-bromomethylpyridine (4.3
g, 25 mmol) was added to a benzene solution (30 mL) of
triphenylphosphine (6.6 g, 25 mmol), and the mixture was
stirred at reflux overnight. The precipitates were collected by
filtration, and washed with benzene to afford the crude product
as a yellow powder. Charcoal was added to a CHCl3 solution of
the crude product, and the black suspension was stirred for
several minutes before the charcoal was filtered off. The filtrate
was evaporated to dryness to leave a white powder. The residual
powder was recrystallized from n-hexane to give (2-pyridyl-
598 (6.6), 558 (22.8), 428 (510.3), 313 (44.7). cis-2 was prepared
similarly to trans-2 in 77% yield. cis-2: FAB-MS for
C51H33N5Zn (MHϩ): m/z 780. Mp >252 ЊC (decomp.). 1H NMR
(C6D6): δ 3.5 (br, 1H, 6-pyridyl-H), 5.3 (t, 1H, 5-pyridyl-H), 6.0
3
(t, 1H, 4-pyridyl), 6.2 and 6.9 (2 d, both 1H, JHH = 12.3 Hz,
CH᎐CH), 6.3 (m, 2H, 3-pyridyl), 7.2 (t, 1H, o-phenyl), 7.3
᎐
(t, 1H, m-phenyl), 7.6–7.9 (m, 11H, m-phenyl and p-phenyl),
8.3–8.8 (m, 7H, o-phenyl), 8.9, 9.2, and 9.4 (3 d, 8H, pyrrole).
UV–vis (CHCl3): λmax/nm (10Ϫ3 εmax) 601 (6.2), 560 (19.0), 430
(430.1).
J. Chem. Soc., Perkin Trans. 1, 2002, 1826–1830
1829